Loading…

Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study

The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae -producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases 2008-11, Vol.27 (11), p.1113-1117
Main Authors: Bertrand, X., Mouchot, L., Jebabli, M., Bajolet, O., Aho, S., Blech, M.-F., Eloy, C., Floret, N., Gayet, S., Talon, D., Tronel, H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33
cites cdi_FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33
container_end_page 1117
container_issue 11
container_start_page 1113
container_title European journal of clinical microbiology & infectious diseases
container_volume 27
creator Bertrand, X.
Mouchot, L.
Jebabli, M.
Bajolet, O.
Aho, S.
Blech, M.-F.
Eloy, C.
Floret, N.
Gayet, S.
Talon, D.
Tronel, H.
description The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae -producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of MRSA per 1,000 patient-days decreased significantly from 0.55 in 2004 to 0.45 in 2006. This trend was observed in medicine and surgery units, whereas MRSA incidence was stable in intensive care, paediatric and obstetric units. The incidence of blood cultures positive for MRSA remained stable at 0.04 per 1,000 patient-days. Conversely, the incidence of ESBLE increased significantly from 0.04 in 2004 to 0.08 in 2006. This increase was caused by the spread of ESBLE-producing Escherichia coli . The mean consumption of alcohol-based gel and solution (ABS), expressed in litres per 1,000 patient-days, was 3.3 in 2002, 4.5 in 2003, 5.4 in 2004 and 6.4 in 2005. There was no association between the consumption of ABS and MRSA incidence. These findings suggest that the French recommendations for the control of multi-drug-resistant bacteria (MDRB) have been effective in reducing, or at least stabilising, the incidence of MRSA in an international context of general increase. However, the diffusion of ESBLE-producing E. coli is a matter of concern and should be carefully monitored.
doi_str_mv 10.1007/s10096-008-0536-0
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00341661v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>872125388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33</originalsourceid><addsrcrecordid>eNp9ks9uEzEQxlcIRNPCA3BBPkFzMPjP7trLLVQpRQpCIuW8mtizjatdb7C9iLxW34AX4JlwlAhuvXis8e_7NBp_RfGKs3ecMfU-5rOpKWOaskrmy5NixktZ0VIq-bSYsUaWtFFCnhXnMd6zrNFKPS_OuC61FpWeFb9vA3obydiRAdPWGdf3ztOA0cUEPpF1gt12349mNGaKBKaAuVx--bZezAl4S5Y-YRg3YHJxYBCQ7sJoJ-P8HcFfKdujpXGHJoVpIH8eaJ9ZGCAiuVyuP66Wc-I8QYjZwJPrAN7gBwIkbQMi3SMEMkx9ctSgTwEzbJzFDJGYJrt_UTzroI_48lQviu_Xy9urG7r6-unz1WJFTcl0ymuQooEOOyMkZ7qxFoF1inHWgKo3kqtqA5tKlcA0VlYopSphhChtZ23XSXlRzI--W-jbXXADhH07gmtvFqv20GNMlryu-U-e2bdHNm_ix4QxtYOLBvsePI5TbLUSXFRS60y-eZSsG1UzJVQG-RE0YYwxYPdvBs7aQxraYxryGLo9pKFlWfP6ZD5tBrT_Fafvz4A4AjE_-TsM7f04BZ_X-IjrX7sbwyg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69760727</pqid></control><display><type>article</type><title>Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study</title><source>Springer Nature</source><creator>Bertrand, X. ; Mouchot, L. ; Jebabli, M. ; Bajolet, O. ; Aho, S. ; Blech, M.-F. ; Eloy, C. ; Floret, N. ; Gayet, S. ; Talon, D. ; Tronel, H.</creator><creatorcontrib>Bertrand, X. ; Mouchot, L. ; Jebabli, M. ; Bajolet, O. ; Aho, S. ; Blech, M.-F. ; Eloy, C. ; Floret, N. ; Gayet, S. ; Talon, D. ; Tronel, H.</creatorcontrib><description>The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae -producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of MRSA per 1,000 patient-days decreased significantly from 0.55 in 2004 to 0.45 in 2006. This trend was observed in medicine and surgery units, whereas MRSA incidence was stable in intensive care, paediatric and obstetric units. The incidence of blood cultures positive for MRSA remained stable at 0.04 per 1,000 patient-days. Conversely, the incidence of ESBLE increased significantly from 0.04 in 2004 to 0.08 in 2006. This increase was caused by the spread of ESBLE-producing Escherichia coli . The mean consumption of alcohol-based gel and solution (ABS), expressed in litres per 1,000 patient-days, was 3.3 in 2002, 4.5 in 2003, 5.4 in 2004 and 6.4 in 2005. There was no association between the consumption of ABS and MRSA incidence. These findings suggest that the French recommendations for the control of multi-drug-resistant bacteria (MDRB) have been effective in reducing, or at least stabilising, the incidence of MRSA in an international context of general increase. However, the diffusion of ESBLE-producing E. coli is a matter of concern and should be carefully monitored.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-008-0536-0</identifier><identifier>PMID: 18488258</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>beta-Lactamases - biosynthesis ; Biomedical and Life Sciences ; Biomedicine ; Concise Article ; Enterobacteriaceae - enzymology ; Enterobacteriaceae - isolation &amp; purification ; Enterobacteriaceae Infections - epidemiology ; Enterobacteriaceae Infections - microbiology ; Escherichia coli ; France - epidemiology ; Hand Disinfection - methods ; Hospitals ; Humans ; Incidence ; Infection Control - methods ; Internal Medicine ; Life Sciences ; Medical Microbiology ; Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification ; Microbiology and Parasitology ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - microbiology ; Staphylococcus aureus</subject><ispartof>European journal of clinical microbiology &amp; infectious diseases, 2008-11, Vol.27 (11), p.1113-1117</ispartof><rights>Springer-Verlag 2008</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33</citedby><cites>FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33</cites><orcidid>0000-0003-4114-7263</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18488258$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00341661$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Bertrand, X.</creatorcontrib><creatorcontrib>Mouchot, L.</creatorcontrib><creatorcontrib>Jebabli, M.</creatorcontrib><creatorcontrib>Bajolet, O.</creatorcontrib><creatorcontrib>Aho, S.</creatorcontrib><creatorcontrib>Blech, M.-F.</creatorcontrib><creatorcontrib>Eloy, C.</creatorcontrib><creatorcontrib>Floret, N.</creatorcontrib><creatorcontrib>Gayet, S.</creatorcontrib><creatorcontrib>Talon, D.</creatorcontrib><creatorcontrib>Tronel, H.</creatorcontrib><title>Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study</title><title>European journal of clinical microbiology &amp; infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae -producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of MRSA per 1,000 patient-days decreased significantly from 0.55 in 2004 to 0.45 in 2006. This trend was observed in medicine and surgery units, whereas MRSA incidence was stable in intensive care, paediatric and obstetric units. The incidence of blood cultures positive for MRSA remained stable at 0.04 per 1,000 patient-days. Conversely, the incidence of ESBLE increased significantly from 0.04 in 2004 to 0.08 in 2006. This increase was caused by the spread of ESBLE-producing Escherichia coli . The mean consumption of alcohol-based gel and solution (ABS), expressed in litres per 1,000 patient-days, was 3.3 in 2002, 4.5 in 2003, 5.4 in 2004 and 6.4 in 2005. There was no association between the consumption of ABS and MRSA incidence. These findings suggest that the French recommendations for the control of multi-drug-resistant bacteria (MDRB) have been effective in reducing, or at least stabilising, the incidence of MRSA in an international context of general increase. However, the diffusion of ESBLE-producing E. coli is a matter of concern and should be carefully monitored.</description><subject>beta-Lactamases - biosynthesis</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Concise Article</subject><subject>Enterobacteriaceae - enzymology</subject><subject>Enterobacteriaceae - isolation &amp; purification</subject><subject>Enterobacteriaceae Infections - epidemiology</subject><subject>Enterobacteriaceae Infections - microbiology</subject><subject>Escherichia coli</subject><subject>France - epidemiology</subject><subject>Hand Disinfection - methods</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infection Control - methods</subject><subject>Internal Medicine</subject><subject>Life Sciences</subject><subject>Medical Microbiology</subject><subject>Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification</subject><subject>Microbiology and Parasitology</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus aureus</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9ks9uEzEQxlcIRNPCA3BBPkFzMPjP7trLLVQpRQpCIuW8mtizjatdb7C9iLxW34AX4JlwlAhuvXis8e_7NBp_RfGKs3ecMfU-5rOpKWOaskrmy5NixktZ0VIq-bSYsUaWtFFCnhXnMd6zrNFKPS_OuC61FpWeFb9vA3obydiRAdPWGdf3ztOA0cUEPpF1gt12349mNGaKBKaAuVx--bZezAl4S5Y-YRg3YHJxYBCQ7sJoJ-P8HcFfKdujpXGHJoVpIH8eaJ9ZGCAiuVyuP66Wc-I8QYjZwJPrAN7gBwIkbQMi3SMEMkx9ctSgTwEzbJzFDJGYJrt_UTzroI_48lQviu_Xy9urG7r6-unz1WJFTcl0ymuQooEOOyMkZ7qxFoF1inHWgKo3kqtqA5tKlcA0VlYopSphhChtZ23XSXlRzI--W-jbXXADhH07gmtvFqv20GNMlryu-U-e2bdHNm_ix4QxtYOLBvsePI5TbLUSXFRS60y-eZSsG1UzJVQG-RE0YYwxYPdvBs7aQxraYxryGLo9pKFlWfP6ZD5tBrT_Fafvz4A4AjE_-TsM7f04BZ_X-IjrX7sbwyg</recordid><startdate>20081101</startdate><enddate>20081101</enddate><creator>Bertrand, X.</creator><creator>Mouchot, L.</creator><creator>Jebabli, M.</creator><creator>Bajolet, O.</creator><creator>Aho, S.</creator><creator>Blech, M.-F.</creator><creator>Eloy, C.</creator><creator>Floret, N.</creator><creator>Gayet, S.</creator><creator>Talon, D.</creator><creator>Tronel, H.</creator><general>Springer-Verlag</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-4114-7263</orcidid></search><sort><creationdate>20081101</creationdate><title>Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study</title><author>Bertrand, X. ; Mouchot, L. ; Jebabli, M. ; Bajolet, O. ; Aho, S. ; Blech, M.-F. ; Eloy, C. ; Floret, N. ; Gayet, S. ; Talon, D. ; Tronel, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>beta-Lactamases - biosynthesis</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Concise Article</topic><topic>Enterobacteriaceae - enzymology</topic><topic>Enterobacteriaceae - isolation &amp; purification</topic><topic>Enterobacteriaceae Infections - epidemiology</topic><topic>Enterobacteriaceae Infections - microbiology</topic><topic>Escherichia coli</topic><topic>France - epidemiology</topic><topic>Hand Disinfection - methods</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infection Control - methods</topic><topic>Internal Medicine</topic><topic>Life Sciences</topic><topic>Medical Microbiology</topic><topic>Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification</topic><topic>Microbiology and Parasitology</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bertrand, X.</creatorcontrib><creatorcontrib>Mouchot, L.</creatorcontrib><creatorcontrib>Jebabli, M.</creatorcontrib><creatorcontrib>Bajolet, O.</creatorcontrib><creatorcontrib>Aho, S.</creatorcontrib><creatorcontrib>Blech, M.-F.</creatorcontrib><creatorcontrib>Eloy, C.</creatorcontrib><creatorcontrib>Floret, N.</creatorcontrib><creatorcontrib>Gayet, S.</creatorcontrib><creatorcontrib>Talon, D.</creatorcontrib><creatorcontrib>Tronel, H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bertrand, X.</au><au>Mouchot, L.</au><au>Jebabli, M.</au><au>Bajolet, O.</au><au>Aho, S.</au><au>Blech, M.-F.</au><au>Eloy, C.</au><au>Floret, N.</au><au>Gayet, S.</au><au>Talon, D.</au><au>Tronel, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study</atitle><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2008-11-01</date><risdate>2008</risdate><volume>27</volume><issue>11</issue><spage>1113</spage><epage>1117</epage><pages>1113-1117</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae -producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of MRSA per 1,000 patient-days decreased significantly from 0.55 in 2004 to 0.45 in 2006. This trend was observed in medicine and surgery units, whereas MRSA incidence was stable in intensive care, paediatric and obstetric units. The incidence of blood cultures positive for MRSA remained stable at 0.04 per 1,000 patient-days. Conversely, the incidence of ESBLE increased significantly from 0.04 in 2004 to 0.08 in 2006. This increase was caused by the spread of ESBLE-producing Escherichia coli . The mean consumption of alcohol-based gel and solution (ABS), expressed in litres per 1,000 patient-days, was 3.3 in 2002, 4.5 in 2003, 5.4 in 2004 and 6.4 in 2005. There was no association between the consumption of ABS and MRSA incidence. These findings suggest that the French recommendations for the control of multi-drug-resistant bacteria (MDRB) have been effective in reducing, or at least stabilising, the incidence of MRSA in an international context of general increase. However, the diffusion of ESBLE-producing E. coli is a matter of concern and should be carefully monitored.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>18488258</pmid><doi>10.1007/s10096-008-0536-0</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-4114-7263</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0934-9723
ispartof European journal of clinical microbiology & infectious diseases, 2008-11, Vol.27 (11), p.1113-1117
issn 0934-9723
1435-4373
language eng
recordid cdi_hal_primary_oai_HAL_hal_00341661v1
source Springer Nature
subjects beta-Lactamases - biosynthesis
Biomedical and Life Sciences
Biomedicine
Concise Article
Enterobacteriaceae - enzymology
Enterobacteriaceae - isolation & purification
Enterobacteriaceae Infections - epidemiology
Enterobacteriaceae Infections - microbiology
Escherichia coli
France - epidemiology
Hand Disinfection - methods
Hospitals
Humans
Incidence
Infection Control - methods
Internal Medicine
Life Sciences
Medical Microbiology
Methicillin-Resistant Staphylococcus aureus - isolation & purification
Microbiology and Parasitology
Staphylococcal Infections - epidemiology
Staphylococcal Infections - microbiology
Staphylococcus aureus
title Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20of%20methicillin-resistant%20Staphylococcus%20aureus%20(MRSA)%20and%20Enterobacteriaceae-producing%20extended-spectrum%20%CE%B2-lactamase%20(ESBLE)%20in%20eastern%20France:%20a%20three-year%20multi-centre%20incidence%20study&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Bertrand,%20X.&rft.date=2008-11-01&rft.volume=27&rft.issue=11&rft.spage=1113&rft.epage=1117&rft.pages=1113-1117&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-008-0536-0&rft_dat=%3Cproquest_hal_p%3E872125388%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69760727&rft_id=info:pmid/18488258&rfr_iscdi=true